DrugsControl Media Services

News Detail

Study: Further Post-Marketing Research Warranted for Infliximab and Its Biosimilars (24-12-2017)

Cranbury, 23 Dec 2017: The European Union has had over a decade of experience with biosimilar therapies, and has collected real-world data concerning the use of these therapies in routine practice. A new study, accepted for View Details

Source : The Center for Biosimilars

Related News